🎉 Health Canada Provides a No Objection Letter for ATMA’s N500 Phase II Clinical Trial Application

About
Trials
Training
Resources
Contact
Live Webinars

Contact us

If you have questions or you’d like to get in touch, please don’t hesitate to contact us. We’ll get back to you as soon as we can.

2303 4 St SW, T2S 2S7
Calgary, Alberta, Canada

Facebook Twitter Instagram Linkedin

Company

About
Careers
Clinical Trials
Contact

Programs

Introduction to Psychedelic-assisted Therapy
Psilocybin-assisted Therapy Program

Resources

Blog
News & Media Releases
Psychedelic Exposé
Oregon Services
Free Class

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of these cookies.

Do not sell my personal information.

Cookie settings ACCEPT

Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT